TAGRISSO

Identification of Tagrisso

No description

Google image searchProduct monograph

Active ingredient

osimertinib (osimertinib mesylate), 40 MG

DIN: 02456214

Dosage form(s): TABLET

Route(s) of administration: ORAL

Schedule: Prescription

Company: ASTRAZENECA CANADA INC

Date: 19-JUL-2016

ATC:

• L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
• L01E — PROTEIN KINASE INHIBITORS (ATC, ATC/DDD)
• L01EB — Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (ATC, ATC/DDD)
• L01EB04 — OSIMERTINIB (ATC/DDD)

Reference brand drug: Tagrisso

External Links for Tagrisso

Search on Google

• Tagrisso side effects
• Tagrisso dosage
• osimertinib side effects
• osimertinib dosage

Astrazeneca Canada Inc

Go to AstraZeneca website to see drug product details. Sometimes you can find tagrisso photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.